Search

everythinglearnresearchcommunity

for

Search:↓

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Male infertility and genitourinary birth defects are often linked to genetic issues.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Male C57BL/6 mice show age-related fluctuations in certain hormones and their ratios in both blood and hair.

Corticosterone makes ethanol more effective at blocking brain processes important for learning and memory.

Natural products may be safer and effective alternatives for managing heart attacks.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Allopregnanolone changes gene expression in glioblastoma cells.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

The glucocorticoid receptor helps protect skin from tumors and other issues.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Tai Chi and Wuqinxi, combined with medication, effectively lower blood pressure.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Adult female acne is complex and requires a combination of treatments for effective management.